UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 51

of 'Systemic therapy for advanced non-small cell lung cancer with an activating mutation in the epidermal growth factor receptor'

51
TI
Update to Rociletinib Data with the RECIST Confirmed Response Rate.
AU
Sequist LV, Soria JC, Camidge DR
SO
N Engl J Med. 2016;374(23):2296.
 
AD
Massachusetts General Hospital, Boston, MA lvsequist@partners.org.
PMID